Companies: 10,795·Total market cap: $144.5T
Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corporation

OCSLNASDAQFinancial Services● Active
$11.87
$-0.05(-0.42%)
Market Cap$1.0B
P/E Ratio
52W High$14.77
52W Low$10.63
Overview

Oaktree Specialty Lending Corporation (OCSL) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · OCSL · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-092024-092023-092022-092021-09
Operating Activities
Net Income$0.03B$0.06B$0.12B$0.03B$0.24B
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital$0.02B$0.07B($0.11B)($0.07B)$0.02B
Net Cash from Operations$0.14B$0.02B$0.23B$0.02B($0.23B)
Investing Activities
Capital Expenditure$0.00B$0.00B$0.00B$0.00B$0.00B
Purchases of Investments($0.96B)($1.28B)($0.74B)($0.70B)($1.12B)
Sales of Investments$1.04B$1.09B$0.91B$0.69B$0.79B
Net Cash from Investing$0.09B$0.00B$0.00B$0.00B$0.00B
Financing Activities
Common Stock Repurchased($0.01B)($0.00B)($0.00B)($0.00B)($0.00B)
Dividends Paid($0.15B)($0.18B)($0.18B)($0.12B)($0.08B)
Debt Issued / Repaid($0.17B)($0.00B)$0.08B$0.07B$0.32B
Net Cash from Financing($0.23B)($0.09B)($0.11B)($0.03B)$0.22B
Free Cash Flow
Free Cash Flow$0.14B$0.02B$0.23B$0.02B($0.23B)
FCF Margin %(computed)47.51%10.24%96.59%26.03%-82.68%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more Oaktree Specialty Lending Corporation data

About Oaktree Specialty Lending Corporation (OCSL) Cash Flow Statement

Oaktree Specialty Lending Corporation generated operating cash flow of $0.14B and free cash flow of $0.14B for 2025 — a FCF margin of 47.51%. Capital expenditure was $0.00B.

Frequently asked questions

OCSL · 4 questions

Oaktree Specialty Lending Corporation generated free cash flow of $0.14B for 2025, up 646.5% year-over-year.

OCSL free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10